medical cannabis

September 2, 2018

State Lawmakers: Medical Marijuana Should Get a Pass in Schools

It seems parents and schools are finally giving more thought to children and the ailments that can be treated with medical marijuana. Delaware News Journal reported an increasing number of parents are turning to cannabis for their children with especially serious or rare conditions. It’s no wonder then that California lawmakers recently passed a bill to allow medical marijuana on school premises.

SB-1127 was introduced by Calif. Sen. Jerry Hill (D-San Mateo) and has passed both houses of the state legislature. Ultimately, the bill would leave it up to school districts and boards of education to decide whether or not to allow medical marijuana on school grounds. While it’s noble to allow school district to have some autonomy, this decision could lead to much confusion and unnecessary distress. Prop 64 allowed cities in California to maintain a ban on sales and cultivation at their own discretion, and it has led to a great deal of Californians not being able to full participate in the cannabis economies they voted to legalize. Similarly, the most vulnerable students and their parents could very well be pigeon-holed by rigid district officials and judgmental peers who can’t understand the complex decisions a parent must make to ensure their child has the best care possible. After all, cannabis generally isn’t recommended by physicians for children except in severe cases.
Continue reading

August 31, 2018

Free Weed Comes With a Hefty Price Tag

By Cannabis Law Group

A recent bill out of the California state house would make marijuana compassionate-care programs exempt from the substantial state taxes on the medical cannabis that they supply to patients in need. SB 829 corrects a hole in Proposition 64, which saddled these not-for-profit organizations with taxes. The Compassionate Use Act of 1996 made medical marijuana legal in California, which spurred the birth of compassionate-care programs for patients with serious health issues and financial restraints. According to NORML, these organizations have been able to donate product and function tax-free up until this year when recreational marijuana became legal.

What did recreational legalization have to do with medical marijuana patients and associated care programs? As our marijuana attorneys can explain, after voters approved Proposition 64, government representatives and officials began ironing out how the recreational program would work. It was determined a set of guidelines was needed that could pull together the medical marijuana industry (which had been active for 20 years) with the new recreational cannabis law. That is when MAUCRSA (Medicinal And Adult-Use Cannabis Regulatory Safety Act) was born. What was intended to streamline rules and make things easier for business owners, customers, and law enforcement officials ended up strapping medical marijuana institutions with a significant number of regulations they previously did not have to follow. Continue reading

August 21, 2018

Newsflash: DEA Finally Recognizes Value of More Cannabis Research

By Cannabis Law Group

It’s about time. The Drug Enforcement Administration is moving to increase the amount of cannabis to be legally medical cannabis grown for research purposes in the U.S. and decrease the amount of opioid drugs produced under the group’s watch. You heard that right. The same organization whose leaders for years have been wringing their collective hands over marijuana, who said we simply did not know enough about its effects, who defended its Schedule I classification, might finally be waking up to smell the coffee the rest of the country has been happily sipping for some time now.

According to a report from Forbes, a new Federal Register filing shows the agency increasing allowance of cannabis plants to 5,400 pounds in 2019, more than five times the 1,000 pounds the department OK’d this year. Representatives of the department said the move was necessary to meet the demands of the medical and scientific communities for research purposes. Of course this demand is nothing new. Health care providers, laboratories, and medical schools have been desperate for proper research on cannabis for decades. California medical practitioners have been using limited studies, anecdotal evidence, and trial and error to treat patients since medical marijuana was legalized in the state in 1996 under Proposition 215. Continue reading

August 14, 2018

$32,500 for Medical Cannabis? Are You High?

By Cannabis Law Group

The company that produced the first ever cannabis-derived medicine to be approved for use by the U.S. Food & Drug medical cannabis Administration has revealed to investors the cost of the drug: $32,500 per year. This is reportedly on the low-end of original estimates between $30,000 and $60,000. Epidiolex, made with CBD and used to treat rare forms of childhood epilepsy, is said to be priced competitively with other epilepsy drugs on the market. This, however, is not other epilepsy drugs.

One of the reasons, among many, that marijuana has become so popular for medicinal use is that it is relatively inexpensive compared to other treatments, even without the help of insurance companies to cover the costs. Some markup by pharmaceutical companies is to be expected to cover testing, research, and ensure consistency and purity of the product. The disparity between cost and price in this instance seems specifically designed to prey on desperate families already prepared to pay top dollar to help their children. In fact, the price was set with the consultation of insurance companies, according to a Business Insider report.

July 29, 2018

Medical Cannabis a Star Player in ‘Concussion Pill’

By Cannabis Law Group

New medical research is revealing significant findings in the treatment of concussions that medical marijuana involves cannabis. A joint project by the University of Miami Miller School of Medicine, Toronto’s Scythian Biosciences Corp., and The Miami Project to Cure Paralysis has led to the development of a “concussion pill,” which combines CBD and an NMDA amino acid anesthetic, according to UPI. Pre-clinical studies on rodents are showing improved cognitive function after traumatic brain injury, more so than either component of the pills does on its own. Trials also showed no adverse effects caused by either component individually nor in combination.

Traumatic brain injuries have made headlines in recent years as more attention has been brought to the dangers of aggressive contact sports, such as football, and the long-term damage caused by concussions. Meanwhile, football players have become some of the strongest advocates for medical marijuana. Cannabis, particularly CBD, has proven to be effective at treating chronic pain caused by sport-related injuries, and does not have the addictive properties of opioids, which are typically prescribed for such injuries. Other players suffer from conditions unrelated to sports, but using medical marijuana has made it possible for them to enjoy activities with fewer limitations. For example, medical marijuana is proving to be a breakthrough treatment for severe seizures, paving the way for people with epilepsy to perform at a competitive level like never before. All of these factors make athletes ideal for receiving the benefits of medical marijuana treatments. Yet continued backward thinking about the drug is holding us back.
Continue reading

April 2, 2018

Medical Marijuana Study in Israel Lights Way for Cancer Treatments

By Cannabis Law Group

Here in California, we have more than 20 years of anecdotal evidence of the ways medical marijuana can be used to treat a variety of ailments. Thanks to the Compassionate Use Act of 1996, patients have been reaping the benefits of cannabis for everything from glaucoma to anxiety and chronic pain. Unfortunately, the research that would help independently establish these things has largely been stifled in the U.S., owing largely to the federal policy that classifies marijuana as a Schedule I narcotic. Meanwhile, as reported by U.S. News & World Report, Israel has become a leader in marijuana research – and one of the latest findings of Israeli researchers underscores the medicinal properties of marijuana for cancer patients.

Published in the European Journal of Internal Medicine, the study analyzes the effects of cannabis on symptoms related to cancer and cancer treatments. These include nausea, vomiting, headaches, weakness, pain, and more. According to the study, 1,046 out of 1,742 reported success in overcoming these symptoms after six months. This total did not include participants who passed away, switched cannabis providers, or did not respond to questionnaires. The study looked mostly at patients who were at an advanced stage of cancer and on average 60-years-old. These factors meant a quarter of patients died before the study was over, but even many of those patients reported having the pain of their condition eased by cannabis.

March 23, 2018

Med Students Must Learn About Medical Marijuana

By Cannabis Law Group

It’s been more than 20 years since California legalized medical marijuana with the Compassionate Use Act of 1996. Much of the country is just now catching up to what California and our trusted attorneys have known for a long time: That marijuana is a safe and effective treatment for many illnesses and ailments. So safe, in fact, that laws are expanding to open up marijuana for recreational consumption as well, with California implementing Proposition 64 Jan. 1. We are now one of 29 states that has some form of cannabis legalization.

But we also know the more things change, the more they stay the same.

High Times recently delved into the issue of medical schools and teaching about medical marijuana to students. One medical journal study last year showed that 90 percent of med students don’t learn anything about marijuana in medical school. Less than 10 percent of medical schools have any sort of medical marijuana curriculum. And roughly 25 percent of graduates wouldn’t even feel prepared to talk about cannabis as an option with a patient.